Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.

Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.

Congenital myasthenic syndromes (CMS) are a group of inherited disorders that arise from impaired signal transmission at the neuromuscular synapse. They are characterized by fatigable muscle weakness. This is a heterogenous group of disorders with 15 different genes implicated in the development of...

Full description

Bibliographic Details
Main Authors:	Belaya, K, Finlayson, S, Cossins, J, Liu, W, Maxwell, S, Palace, J, Beeson, D
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
by: Finlayson, S, et al.
Published: (2013)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
by: Finlayson, S, et al.
Published: (2013)

Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates
by: Belaya, K, et al.
Published: (2012)

Congenital myasthenic syndrome caused by mutations in DPAGT.
by: Klein, A, et al.
Published: (2015)

Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates.
by: Belaya, K, et al.
Published: (2012)

Clinical features in a large Iranian family with a limb-girdle congenital myasthenic syndrome due to a mutation in DPAGT1.
by: Basiri, K, et al.
Published: (2013)

Congenital myasthenic syndromes: an update.
by: Finlayson, S, et al.
Published: (2013)

Congenital myasthenic syndromes due to mutations in ALG2 and ALG14
by: Cossins, J, et al.
Published: (2013)

The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
by: Cossins, J, et al.
Published: (2012)

Congenital myasthenic syndromes due to mutations in ALG2 and ALG14
by: Cossins, J, et al.
Published: (2013)

The congenital myasthenic syndromes.
by: Palace, J, et al.
Published: (2008)

Congenital myasthenic syndromes.
by: Beeson, D, et al.
Published: (1997)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
by: Beeson, D, et al.
Published: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction.
by: Beeson, D, et al.
Published: (2008)

The genetic diagnosis of congenital myasthenic syndromes (CMS)
by: Man, S, et al.
Published: (2005)

Congenital myasthenic syndromes and the neuromuscular junction.
by: Cruz, P, et al.
Published: (2014)

Therapeutic strategies for congenital myasthenic syndromes
by: Lee, M, et al.
Published: (2018)

Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR
by: Zoltowska, K, et al.
Published: (2013)

Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR.
by: Zoltowska, K, et al.
Published: (2013)

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
by: Lashley, D, et al.
Published: (2010)

Congenital myasthenic syndrome due to mutations in MUSK suggests that the level of MuSK phosphorylation is crucial for governing synaptic structure
by: Rodríguez Cruz, PM, et al.
Published: (2019)

A novel cardiac phenotype in patients with GFPT1 or DPAGT1 mutations
by: Lewis, A, et al.
Published: (2014)

The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes
by: Rodríguez Cruz, P, et al.
Published: (2018)

Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.
by: Finlayson, S, et al.
Published: (2013)

CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME
by: Lashley, D, et al.
Published: (2009)

CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn.
by: Müller, J, et al.
Published: (2006)

Impaired neurotransmission in a mouse model of the slow channel congenital myasthenic syndrome is improved by the sympathomimetic drug ephedrine
by: Webster, R, et al.
Published: (2011)

A <i>Dpagt1</i> Missense Variant Causes Degenerative Retinopathy without Myasthenic Syndrome in Mice
by: Lillian F. Hyde, et al.
Published: (2022-10-01)

DOK7 congenital myasthenic syndrome.
by: Palace, J
Published: (2012)

A nationwide service for the diagnosis and treatment of congenital myasthenic syndromes
by: Burke, G, et al.
Published: (2006)

A rare c.183_187dupCTCAC mutation of the acetylcholine receptor CHRNE gene in a South Asian female with congenital myasthenic syndrome: a case report
by: Chang, T, et al.
Published: (2016)

Muscle magnetic resonance imaging in congenital myasthenic syndromes
by: Finlayson, S, et al.
Published: (2016)

Myasthenic syndromes due to defects in COL13A1 and in the N‐linked glycosylation pathway
by: Beeson, D, et al.
Published: (2018)

Synaptic dysfunction in congenital myasthenic syndromes.
by: Beeson, D
Published: (2012)

Structural abnormalities of the AChR caused by mutations underlying congenital myasthenic syndromes.
by: Beeson, D, et al.
Published: (2003)

Congenital myasthenic syndromes: recent advances
by: Beeson, D
Published: (2016)

Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.
by: Guergueltcheva, V, et al.
Published: (2011)

Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations
by: Guergueltcheva, V, et al.
Published: (2011)

Congenital myasthenic syndrome patients due to AChR epsilon subunit mutations
by: Bonifati, D, et al.
Published: (2004)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
by: Beeson, D
Published: (2008)